國立虎尾科技大學 |

Neuroimaging Markers of Genetic Risk for Alzheimer's Disease in Cognitively Healthy Cohorts.

Record Type:	Language materials, manuscript : Monograph/item
Title/Author:	Neuroimaging Markers of Genetic Risk for Alzheimer's Disease in Cognitively Healthy Cohorts./
Author:	Harrison, Theresa Maria.
Description:	1 online resource (243 pages)
Notes:	Source: Dissertation Abstracts International, Volume: 78-05(E), Section: B.
Subject:	Neurosciences. -
Online resource:	click for full text (PQDT)
ISBN:	9781369413786

Neuroimaging Markers of Genetic Risk for Alzheimer's Disease in Cognitively Healthy Cohorts.
Harrison, Theresa Maria.

Neuroimaging Markers of Genetic Risk for Alzheimer's Disease in Cognitively Healthy Cohorts. - 1 online resource (243 pages)

Source: Dissertation Abstracts International, Volume: 78-05(E), Section: B.

Thesis (Ph.D.)--University of California, Los Angeles, 2016.

Includes bibliographical references

Drugs developed to slow, halt or reverse the progression of Alzheimer's Disease (AD) have failed to alter the course of the disease in clinical trials. One possible explanation is that drugs need to be administered earlier, before the onset of clinical symptoms. AD-related pathological processes that occur before clinical symptoms emerge define the preclinical phase of the disease. Neuroimaging biomarkers and genetics together present a powerful system for characterizing potential preclinical changes in the brain. The work presented in this volume is predicated on the need for a better understanding of genetic risk and neuroimaging biomarkers for AD in healthy adults. In Chapter 1, a thorough review of neuroimaging genetics in AD is presented. The studies described in Chapters 2 and 3 explore the relationship between functional connectivity and the apolioprotein E (APOE) risk allele, APOEepsilon4. In the first study a pattern of context-dependent connectivity was uncovered that indicates APOEepsilon4 carriers disengage key cortical regions from the hippocampus during a memory task. These findings support the growing consensus that functional connectivity changes may be among the earliest preclinical markers of AD-related changes in the brain. The second study utilized resting state fMRI scans from 570 healthy college-age adults. Young carriers of APOEepsilon4 showed decreased connectivity between key regions involved in AD and increased segregation of task-positive and task-negative regions. This work is a crucial reminder that genetic risk for AD has important implications across the lifespan and that gene-biomarker associations must be tracked over time to identify changes that might be signs of imminent clinical decline. In Chapter 4, the focus expands to include additional genetic risk factors for AD beyond APOE. This study is the first to show that a genetic risk score for AD is significantly associated with hippocampal thinning over two years in a cohort of older, cognitively healthy adults. Finally, Chapter 5 is a call for the further development of polygenic approaches to studying neuroimaging markers of genetic risk for AD. Together, this volume represents steps toward understanding how genetic risk for AD and neuroimaging can be used to identify individuals at greatest risk for decline.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2018

Mode of access: World Wide Web

ISBN: 9781369413786Subjects--Topical Terms:

593561
Neurosciences.
Index Terms--Genre/Form:

554714
Electronic books.

Neuroimaging Markers of Genetic Risk for Alzheimer's Disease in Cognitively Healthy Cohorts.
LDR:03510ntm a2200313K 4500 001 913668
005 20180622095235.5
006 m o u
007 cr mn||||a|a||
008 190606s2016 xx obm 000 0 eng d
020 $a 9781369413786
035 $a (MiAaPQ)AAI10246120
035 $a (MiAaPQ)ucla:15101
035 $a AAI10246120
040 $a MiAaPQ $b eng $c MiAaPQ
100 1 $a Harrison, Theresa Maria. $3 1186598
245 1 0 $a Neuroimaging Markers of Genetic Risk for Alzheimer's Disease in Cognitively Healthy Cohorts.
264 0 $c 2016
300 $a 1 online resource (243 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertation Abstracts International, Volume: 78-05(E), Section: B.
500 $a Adviser: Susan Y. Bookheimer.
502 $a Thesis (Ph.D.)--University of California, Los Angeles, 2016.
504 $a Includes bibliographical references
520 $a Drugs developed to slow, halt or reverse the progression of Alzheimer's Disease (AD) have failed to alter the course of the disease in clinical trials. One possible explanation is that drugs need to be administered earlier, before the onset of clinical symptoms. AD-related pathological processes that occur before clinical symptoms emerge define the preclinical phase of the disease. Neuroimaging biomarkers and genetics together present a powerful system for characterizing potential preclinical changes in the brain. The work presented in this volume is predicated on the need for a better understanding of genetic risk and neuroimaging biomarkers for AD in healthy adults. In Chapter 1, a thorough review of neuroimaging genetics in AD is presented. The studies described in Chapters 2 and 3 explore the relationship between functional connectivity and the apolioprotein E (APOE) risk allele, APOEepsilon4. In the first study a pattern of context-dependent connectivity was uncovered that indicates APOEepsilon4 carriers disengage key cortical regions from the hippocampus during a memory task. These findings support the growing consensus that functional connectivity changes may be among the earliest preclinical markers of AD-related changes in the brain. The second study utilized resting state fMRI scans from 570 healthy college-age adults. Young carriers of APOEepsilon4 showed decreased connectivity between key regions involved in AD and increased segregation of task-positive and task-negative regions. This work is a crucial reminder that genetic risk for AD has important implications across the lifespan and that gene-biomarker associations must be tracked over time to identify changes that might be signs of imminent clinical decline. In Chapter 4, the focus expands to include additional genetic risk factors for AD beyond APOE. This study is the first to show that a genetic risk score for AD is significantly associated with hippocampal thinning over two years in a cohort of older, cognitively healthy adults. Finally, Chapter 5 is a call for the further development of polygenic approaches to studying neuroimaging markers of genetic risk for AD. Together, this volume represents steps toward understanding how genetic risk for AD and neuroimaging can be used to identify individuals at greatest risk for decline.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2018
538 $a Mode of access: World Wide Web
650 4 $a Neurosciences. $3 593561
655 7 $a Electronic books. $2 local $3 554714
690 $a 0317
710 2 $a ProQuest Information and Learning Co. $3 1178819
710 2 $a University of California, Los Angeles. $b Neuroscience. $3 1186597
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10246120 $z click for full text (PQDT)